These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17047198)

  • 61. Folic acid and risk of prostate cancer: results from a randomized clinical trial.
    Figueiredo JC; Grau MV; Haile RW; Sandler RS; Summers RW; Bresalier RS; Burke CA; McKeown-Eyssen GE; Baron JA
    J Natl Cancer Inst; 2009 Mar; 101(6):432-5. PubMed ID: 19276452
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.
    Wei EK; Giovannucci E; Selhub J; Fuchs CS; Hankinson SE; Ma J
    J Natl Cancer Inst; 2005 May; 97(9):684-92. PubMed ID: 15870439
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ornithine decarboxylase and polyamines in familial adenomatous polyposis.
    Giardiello FM; Hamilton SR; Hylind LM; Yang VW; Tamez P; Casero RA
    Cancer Res; 1997 Jan; 57(2):199-201. PubMed ID: 9000553
    [TBL] [Abstract][Full Text] [Related]  

  • 64. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.
    Moore LE; Huang WY; Chatterjee N; Gunter M; Chanock S; Yeager M; Welch B; Pinsky P; Weissfeld J; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1823-7. PubMed ID: 16030123
    [TBL] [Abstract][Full Text] [Related]  

  • 65. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
    Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):863-70. PubMed ID: 15824157
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps.
    Ulrich CM; Kampman E; Bigler J; Schwartz SM; Chen C; Bostick R; Fosdick L; Beresford SA; Yasui Y; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):427-33. PubMed ID: 10794488
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial.
    Sansbury LB; Bergen AW; Wanke KL; Yu B; Caporaso NE; Chatterjee N; Ratnasinghe L; Schatzkin A; Lehman TA; Kalidindi A; Modali R; Lanza E
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):494-501. PubMed ID: 16537707
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction?
    Ulrich CM; Kampman E; Bigler J; Schwartz SM; Chen C; Bostick R; Fosdick L; Beresford SA; Yasui Y; Potter JD
    Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):659-68. PubMed ID: 10744125
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Celecoxib for the prevention of sporadic colorectal adenomas.
    Bertagnolli MM; Eagle CJ; Zauber AG; Redston M; Solomon SD; Kim K; Tang J; Rosenstein RB; Wittes J; Corle D; Hess TM; Woloj GM; Boisserie F; Anderson WF; Viner JL; Bagheri D; Burn J; Chung DC; Dewar T; Foley TR; Hoffman N; Macrae F; Pruitt RE; Saltzman JR; Salzberg B; Sylwestrowicz T; Gordon GB; Hawk ET;
    N Engl J Med; 2006 Aug; 355(9):873-84. PubMed ID: 16943400
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.
    Ali IU; Luke BT; Dean M; Greenwald P
    Br J Cancer; 2005 Oct; 93(8):953-9. PubMed ID: 16205694
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
    Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
    Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma.
    Chan AT; Hsu M; Zauber AG; Hawk ET; Bertagnolli MM
    Cancer Prev Res (Phila); 2012 Jan; 5(1):61-72. PubMed ID: 22030088
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.
    Kleinstein SE; Heath L; Makar KW; Poole EM; Seufert BL; Slattery ML; Xiao L; Duggan DJ; Hsu L; Curtin K; Koepl L; Muehling J; Taverna D; Caan BJ; Carlson CS; Potter JD; Ulrich CM
    Genes Chromosomes Cancer; 2013 May; 52(5):437-49. PubMed ID: 23404351
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of aspirin on prevention of colorectal cancer: an updated systematic review and meta-analysis of randomized controlled trials.
    Ghaddaf AA; Aziz M; Alomari MS; Abdulhamid AS; Alharbi FA; Mullah AN; Zaidi SF
    Int J Colorectal Dis; 2021 Aug; 36(8):1711-1722. PubMed ID: 33682036
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials.
    Figueiredo JC; Mott LA; Giovannucci E; Wu K; Cole B; Grainge MJ; Logan RF; Baron JA
    Int J Cancer; 2011 Jul; 129(1):192-203. PubMed ID: 21170989
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.
    Ho GY; Xue X; Cushman M; McKeown-Eyssen G; Sandler RS; Ahnen DJ; Barry EL; Saibil F; Bresalier RS; Rohan TE; Baron JA
    J Natl Cancer Inst; 2009 Dec; 101(23):1650-4. PubMed ID: 19822838
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fatty acid desaturase insertion-deletion polymorphism rs66698963 predicts colorectal polyp prevention by the n-3 fatty acid eicosapentaenoic acid: a secondary analysis of the seAFOod polyp prevention trial.
    Sun G; Li YN; Davies JR; Block RC; Kothapalli KS; Brenna JT; Hull MA
    Am J Clin Nutr; 2024 Aug; 120(2):360-368. PubMed ID: 38879016
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
    Passarelli MN; Barry EL; Zhang D; Gangar P; Rees JR; Bresalier RS; McKeown-Eyssen G; Karagas MR; Baron JA
    Br J Dermatol; 2018 Aug; 179(2):337-344. PubMed ID: 29570772
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
    Burn J; Bishop DT; Mecklin JP; Macrae F; Möslein G; Olschwang S; Bisgaard ML; Ramesar R; Eccles D; Maher ER; Bertario L; Jarvinen HJ; Lindblom A; Evans DG; Lubinski J; Morrison PJ; Ho JW; Vasen HF; Side L; Thomas HJ; Scott RJ; Dunlop M; Barker G; Elliott F; Jass JR; Fodde R; Lynch HT; Mathers JC;
    N Engl J Med; 2008 Dec; 359(24):2567-78. PubMed ID: 19073976
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial.
    Benamouzig R; Deyra J; Martin A; Girard B; Jullian E; Piednoir B; Couturier D; Coste T; Little J; Chaussade S
    Gastroenterology; 2003 Aug; 125(2):328-36. PubMed ID: 12891533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.